We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

New Insights Into Cognitive Disorders

A study of 35,000 people has revealed new genetic variations related to cognitive ability providing new hope for the treatment of cognitive disorders of the brain.
News

Brain-on-a-Chip Models Brain Connectivity

Researchers from Harvard University demonstrate the potential of the chip to model neurological and psychiatric diseases.
News

Neurodegeneration Linked To Concussion

Researchers provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in people genetically at risk of Alzheimer's Disease.
News

New Hope for Personalized Lung Cancer Treatment

Researchers have identified distinct tumor types within small cell lung cancer and a targeted drug combination that worked well against one of these specific tumor types.
Neurons Signal Spinal Cord Vascularisation content piece image
News

Neurons Signal Spinal Cord Vascularisation

A study in zebrafish reveals neurons play an important role in signaling blood vessel growth.
News

Positive Allosteric Modulator Improves Neurodegenerative Outcomes

Global collaboration shows positive allosteric modulation of M1 Muscarinic receptors slows prion neurodegeneration and restores memory loss.
News

Deciding When Not To Act On Instinct

Scientists uncover neural connection that can prevent us acting on instinct.
News

Brain cell powerhouses appear good treatment target for stroke, TBI recovery

Cell powerhouses are typically long and lean, but with brain injury such as stroke or trauma, they can quickly become bloated and dysfunctional, say scientists who documented the phenomena in real time for the first time in a living brain.
News

Neural connection keeps instincts in check

Scientists identify the physical connection through which the prefrontal cortex inhibits instinctive behavior.
News

Experiments in mice may help boost newly FDA-approved therapy for spinal muscular atrophy

Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine aimed at this target works as a "booster" in conjunction with a drug called nusinersen that was recently ([US]) Food and Drug Administration- (FDA-) approved to improve symptoms of the disorder in mice.
Advertisement